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Background: Delirium is a common and serious problem among acutely unwell persons. Alhough linked to higher
rates of mortality, institutionalisation and dementia, it remains underdiagnosed. Careful consideration of its
phenomenology is warranted to improve detection and therefore mitigate some of its clinical impact. The
publication of the fifth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association
(DSM-5) provides an opportunity to examine the constructs underlying delirium as a clinical entity.
Discussion: Altered consciousness has been regarded as a core feature of delirium; the fact that consciousness itself
should be physiologically disrupted due to acute illness attests to its clinical urgency. DSM-5 now operationalises
‘consciousness’ as ‘changes in attention’. It should be recognised that attention relates to content of consciousness,
but arousal corresponds to level of consciousness. Reduced arousal is also associated with adverse outcomes. Attention
and arousal are hierarchically related; level of arousal must be sufficient before attention can be reasonably tested.
Summary: Our conceptualisation of delirium must extend beyond what can be assessed through cognitive testing
(attention) and accept that altered arousal is fundamental. Understanding the DSM-5 criteria explicitly in this way offers
the most inclusive and clinically safe interpretation.
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Delirium is an extensive and serious problem in acute
hospitals [1]. It is unquestionably a marker for vulner-
ability, and is associated with adverse outcomes in a
number of settings [2-5]. Fundamentally, the syndrome
represents a decompensation of cerebral function in
response to one or more pathophysiological stressors [6].
Therefore, understanding how to identify delirium can be
central to recognising acute illness in patients of all ages.
The American Psychiatric Association’s fifth edition of the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) revised the diagnostic criteria for delirium. As
the leading organisations in delirium science and practice,
the European Delirium Association (EDA) and American
Delirium Society (ADS) believe that the interpretation of
these revisions warrants comment, in order to improve
clinical practice and patient safety.* Correspondence: daniel.davis@ucl.ac.uk
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this article, unless otherwise stated.The diagnosis of delirium represents an umbrella
construct that was adopted to overcome the termino-
logical chaos existing before DSM-III (1980), when
dozens of terms were used to indicate generalised brain
dysfunction occurring in the context of acute illness or
drug intoxication. These included ‘acute confusional
state’, ‘encephalopathy’, ‘acute brain failure’, ‘ICU psychosis’,
and even ‘subacute befuddlement’ [7,8]. These terms
were not based upon any explicit scientific rationale,
but rather denoted delirium occurring in different pa-
tient populations and/or treatment settings. Combin-
ing all of these clinical constructs under the term
‘delirium’ has resulted in a more coherent approach to
clinical practice and research.
A consistent feature of DSM versions prior to DSM-5
has been the requirement that alterations in the content
(that is, attention) and/or level (that is, arousal) of con-
sciousness are core to the diagnosis of delirium. Delirium
can present as hypoactive or hyperactive states, and may
fluctuate between the two. DSM-III used the term ‘cloud-
ing of consciousness’. DSM-III-R and DSM-IV, while
maintaining the term ‘consciousness’, operationalised thisicensee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted
ium, provided the original work is properly credited. The Creative Commons
ivecommons.org/publicdomain/zero/1.0/) applies to the data made available in
European Delirium Association BMC Medicine 2014, 12:141 Page 2 of 4
http://www.biomedcentral.com/1741-7015/12/141by linking this construct to deficits in attention. This shift
towards attention was driven by a recognition that the
construct ‘consciousness’ was difficult to assess objectively
[9]. It should be appreciated that for consciousness, both
attention and arousal are hierarchically related: it is pos-
sible to have full arousal, but profound inattention (for
example, hypervigilance), but not the other way around
[10]. Therefore, the retention of ‘consciousness’ implied
that level of arousal remained part of the construct of
delirium.
In DSM-5, the term ‘consciousness’ is not used at all
(Table 1). Delirium is now more restrictively defined in
terms of its cognitive features, and the level of arousal
element implicit in prior DSM criteria has been removed.
Moreover, Criterion D states that inattention or changes
in cognition ‘must not occur in the context of a severely
reduced level of arousal such as coma’.
Discussion
The risk of misinterpreting these revised criteria is that
clinicians may focus inappropriately on inattention and
testability, erroneously overlooking the de facto disturb-
ance in consciousness (that is, delirium) that comes with
altered arousal. Criterion D draws attention to the idea
that altered arousal states may exist outside of delirium.
Our view is that this is only the case in the profoundest
possible disturbance of arousal, namely, coma (Figure 1).
Other than coma, the interpretation of Criterion D should
recognise that it is not possible to determine a threshold
to discriminate severe and non-severe levels of arousal. It
is also worth noting, in relation to Criterion E, that
withdrawal of an antipsychotic in a patient with a chronic
psychotic condition, such as schizophrenia, may result inTable 1 Comparing DSM classifications of deliriuma
DSM-5 DS
A. Disturbance in attention (i.e., reduced ability to direct, focus,
sustain, and shift attention) and awareness (reduced orientation
to the environment).
A.
B. The disturbance develops over a short period of time (usually
hours to a few days), represents an acute change from baseline
attention and awareness, and tends to fluctuate in severity during
the course of a day.
B.
C. An additional disturbance in cognition (e.g.memory deficit,
disorientation, language, visuospatial ability, or perception).
C.
D. The disturbances in Criteria A and C are not better explained by
a pre-existing, established or evolving neurocognitive disorder and
do not occur in the context of a severely reduced level of arousal
such as coma.
D.
E. There is evidence from the history, physical examination or
laboratory findings that the disturbance is a direct physiological
consequence of another medical condition, substance intoxication
or withdrawal (i.e. due to a drug of abuse or to a medication), or
exposure to a toxin, or is due to multiple etiologies.
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; DSM-5
aChanges in DSM-5 from DSM-IV shown in italics.a syndrome of increased arousal and acute recurrence of
psychotic symptoms. Although this specific state may
appear to be phenomenologically similar to delirium, it
should not be classified as such.
What kinds of evidence should be required to demon-
strate disturbances in attention, orientation and other cog-
nitive domains? A narrow interpretation of Criterion D
could mean that patients too drowsy to undergo cognitive
testing cannot fulfil Criterion A (inattention and disturbed
orientation to the environment) or Criterion C (deficit in
an additional cognitive domain). That is, patients not
capable of demonstrating ‘inattention’ cannot be assessed
against Criterion A if this is interpreted to mean that
patients must show impaired performance on cognitive
tests of attention or an inability to sustain attention during
interview. Of crucial clinical importance, non-comatose
patients who are too drowsy to demonstrate inattention
by tests or interview might not be classified as having
delirium. This narrow approach would have multiple
negative consequences. The unanimous view of the
Boards of the EDA and ADS is that Criterion D should
include all states of altered arousal (except coma) in the
spectrum of delirium on scientific, practical and clinical
safety grounds.
First, a substantial proportion of patients present to
acute hospitals with reduced consciousness that is severe
enough to affect their ability to engage with cognitive
testing and/or interview. Reduced level of consciousness
is present at least 8% of general hospital admissions [11].
If Criterion D is strictly applied, large numbers of pa-
tients will thus be left unclassified, or labelled with vague
descriptions such as ‘obtunded’ or ‘stuporose’. This is im-
portant, because reduced level of arousal is a powerfulM-IV
Disturbance of consciousness (i.e. reduced clarity of awareness of the
environment) with reduced ability to focus, sustain or shift attention.
A change in cognition or the development of a perceptual disturbance
that is not better accounted for by a pre-existing, established or evolving
dementia.
The disturbance develops over a short period of time (usually hours to
days) and tends to fluctuate during the course of the day
There is evidence from the history, physical examination or laboratory
findings that the disturbance is caused by the direct physiological
consequences of a general medical condition.
, Diagnostic and Statistical Manual of Mental Disorders, fifth edition.
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Figure 1 Overlap between hypoactive delirium and reduced arousal states (hyperactive delirium not included).
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subsequent admission to intensive care [12]. The clinical
approach to such patients is essentially the same as the
approach to verbally communicative patients with delir-
ium. Access to delirium management pathways, present
in increasing numbers of hospitals, is beneficial, and am-
biguity about which non-comatose but acutely mentally
impaired patients undergo such pathways will likely lead
to worse care for some.
Second, there is no clear empirical evidence that non-
comatose patients who are verbally uncommunicative are
different from patients with milder degrees of arousal im-
pairment in whom inattention can readily be demon-
strated through verbal responses. Evidence from animal
and human studies suggests that there is a continuum of
levels of arousal. The little direct empirical evidence that
exists in humans actually suggests that reduced arousal is
highly specific for delirium [13].
Third, segmenting the spectrum of acutely reduced
arousal into ‘delirium’, ‘other’, and ‘coma’ would present
substantial difficulties to both clinicians and researchers.
In non-comatose patients with acutely reduced level of
arousal that is severe enough for them to be unable to
engage verbally, the clinical approach is essentially the
same as in patients who are well enough to communicate.
Therefore, it is not rational to divide the non-coma part of
the spectrum. Moreover, fluctuations in level of arousal
mean that patients could have a diagnosis of delirium in
one part of the day, but then lose this diagnosis (and enter
a vaguely defined category) if they later became so drowsy
that they were unable to communicate verbally. This
degree of fluctuation is observed frequently by clinicians.
Interpreting the criteria in such a way that only part of thespectrum is covered, especially when patients are fluctuat-
ing along this spectrum, is impractical.
Summary
To conclude, an inclusive interpretation of Criteria A and
D is essential. Patients who are not comatose, but have
impaired arousal resulting in an inability to engage in
cognitive testing or interview (for example, drowsiness,
obtundation, stupor or agitation), must be understood
as effectively having inattention. Including such patients
under the umbrella of delirium is more closely aligned
with the scientific evidence and the realities of clinical
practice, and will result in increased patient safety through
broader delirium prevention and identification.
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